Main Menu

Community-effectiveness of the distribution of insecticide-treated bed nets through social marketing antenatal care services in malaria control in rural Burkina Faso

Condition category

Infections and Infestations

Date applied

16/07/2007

Date assigned

19/07/2007

Last edited

19/09/2008

Prospective/Retrospective

Retrospectively registered

Overall trial status

Completed

Recruitment status

No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Prof Olaf Mueller

ORCID ID

Contact details

Im Neuenheimer Feld 324 Heidelberg 69120 Germany

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

D4

Study information

Scientific title

Acronym

Study hypothesis

There is the highly controversial question how African programmes can best reach a sustainable high coverage with Insecticide-Treated bed Nets (ITNs) in young children and pregnant women. Against this background a cluster randomised controlled trial is implemented in Nouna Health District in Burkina Faso to compare two different forms of distribution of ITNs.

Ethics approval

The protocol has been reviewed and approved by the Ethics Committee of the University of Heidelberg (date: 12 th November 2004, ref: L-357/2004) and the local Ethics Committee in Nouna, Burkina Faso.

Study design

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Other

Trial type

Prevention

Patient information sheet

Condition

Malaria

Intervention

Twenty-four peripheral health centres and their catchment areas were randomised to:1. ITN provision to the general population through social marketing, and 2. ITN provision to the general population through social marketing plus free provision to all pregnant women through antenatal services

The total duration of the intervention will be three years, and participants will be followed up for a further two years.

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

1. ITN coverage in households 12 and 24 months after the start of the interventions2. ITN use during pregnancy and infancy

Secondary outcome measures

1. Costs per malaria case and per Disability Adjusted Life Years (DALY) prevented 2. Self-reported information on Antenatal Clinic (ANC) visits 3. Insecticide content on ITN and mortality of vector mosquitoes over time 4. Acceptance of health staff and population

Outcomes will be measured at 12 and 24 months after the start of the interventions